Computer evaluation of drug interactions with P-glycoprotein

Area of Science:

• Pharmacology and Cheminformatics
• Drug Discovery and Development
• Computational Toxicology

Background:

• P-glycoprotein (P-gp) is a key efflux transporter involved in drug absorption, distribution, metabolism, and excretion (ADME).
• Predicting drug interactions with P-gp is crucial for drug efficacy and safety.
• Structure-property relationships are vital for understanding transporter interactions.

Purpose of the Study:

• To develop and validate quantitative structure-activity relationship ((Q)SAR) models for predicting P-glycoprotein (P-gp) substrates and inhibitors.
• To assess the predictive accuracy of these models using independent test sets.
• To provide computational tools for early-stage drug screening and lead optimization.

Main Methods:

• Construction of (Q)SAR models using PASS and GUSAR software.
• Utilizing datasets of 256 P-gp substrates and 94 P-gp inhibitors.
• Validation of models using an 80:20 training-test split.
• Evaluation of prediction accuracy on test samples.

Main Results:

• Achieved 78% prediction accuracy for P-glycoprotein substrate identification using PASS.
• Achieved 89% prediction accuracy for P-glycoprotein inhibitor identification using GUSAR.
• Demonstrated the utility of (Q)SAR models in predicting drug-transporter interactions.

Conclusions:

• The developed (Q)SAR models are effective tools for predicting P-gp substrate and inhibitor activity.
• These models can significantly aid in the drug discovery process by identifying potential drug interactions early.
• Computational approaches like (Q)SAR modeling are valuable for assessing drug safety and efficacy related to P-gp.